WallStreetZenWallStreetZen

NASDAQ: NRBO
Neurobo Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for NRBO

Based on 1 analyst offering 12 month price targets for Neurobo Pharmaceuticals Inc.
Min Forecast
$10.00+146.31%
Avg Forecast
$10.00+146.31%
Max Forecast
$10.00+146.31%

Should I buy or sell NRBO stock?

Based on 1 analyst offering ratings for Neurobo Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NRBO stock forecasts and price targets.

NRBO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-08

1 of 1

Forecast return on equity

Is NRBO forecast to generate an efficient return?
Company
-124.65%
Industry
75.04%
Market
62.12%
NRBO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NRBO forecast to generate an efficient return on assets?
Company
-73.8%
Industry
29.38%
NRBO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NRBO earnings per share forecast

What is NRBO's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$4.89
Avg 2 year Forecast
-$2.28
Avg 3 year Forecast
-$2.56

NRBO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NRBO$4.06$10.00+146.31%Strong Buy
ITRM$1.24$6.00+383.87%Buy
JAGX$3.92N/AN/A
INDP$2.25$12.00+433.33%Buy
MEIP$2.86$7.00+144.76%Hold

Neurobo Pharmaceuticals Stock Forecast FAQ

Is Neurobo Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NRBO) stock is to Strong Buy NRBO stock.

Out of 1 analyst, 1 (100%) are recommending NRBO as a Strong Buy, 0 (0%) are recommending NRBO as a Buy, 0 (0%) are recommending NRBO as a Hold, 0 (0%) are recommending NRBO as a Sell, and 0 (0%) are recommending NRBO as a Strong Sell.

If you're new to stock investing, here's how to buy Neurobo Pharmaceuticals stock.

What is NRBO's earnings growth forecast for 2024-2026?

(NASDAQ: NRBO) Neurobo Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.32%.

Neurobo Pharmaceuticals's earnings in 2024 is -$16,580,000.On average, 2 Wall Street analysts forecast NRBO's earnings for 2024 to be -$23,990,350, with the lowest NRBO earnings forecast at -$26,786,771, and the highest NRBO earnings forecast at -$21,193,929. On average, 2 Wall Street analysts forecast NRBO's earnings for 2025 to be -$11,161,155, with the lowest NRBO earnings forecast at -$12,706,545, and the highest NRBO earnings forecast at -$9,615,764.

In 2026, NRBO is forecast to generate -$12,559,365 in earnings, with the lowest earnings forecast at -$12,559,365 and the highest earnings forecast at -$12,559,365.

What is NRBO's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: NRBO) forecast ROE is -124.65%, which is considered weak.

What is NRBO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NRBO price target, the average NRBO price target is $10.00, with the highest NRBO stock price forecast at $10.00 and the lowest NRBO stock price forecast at $10.00.

The Wall Street analyst predicted that Neurobo Pharmaceuticals's share price could reach $10.00 by May 8, 2025. The average Neurobo Pharmaceuticals stock price prediction forecasts a potential upside of 146.31% from the current NRBO share price of $4.06.

What is NRBO's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: NRBO) Neurobo Pharmaceuticals's current Earnings Per Share (EPS) is -$3.22. On average, analysts forecast that NRBO's EPS will be -$4.89 for 2024, with the lowest EPS forecast at -$5.46, and the highest EPS forecast at -$4.32. On average, analysts forecast that NRBO's EPS will be -$2.28 for 2025, with the lowest EPS forecast at -$2.59, and the highest EPS forecast at -$1.96. In 2026, NRBO's EPS is forecast to hit -$2.56 (min: -$2.56, max: -$2.56).

What is NRBO's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: NRBO) forecast ROA is -73.8%, which is lower than the forecast US Biotechnology industry average of 29.38%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.